- POSITIVE
Quarterly Revenue Lemaitre Vascular Inc Jun-2026 Quarterly Revenue is $70 Million which is growth of 9.6% YoY.
- POSITIVE
Quarterly Net Profit Lemaitre Vascular Inc Jun-2026 Quarterly Net Profit is $17 Million which is growth of 23.7% YoY.
80.992.03(2.57%)
369.8K
XNAS Volume
XNAS 05 Oct, 2026 5:30 PM (EDT)
Lemaitre Vascular Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Forecaster Analyst Estimates for Lemaitre Vascular Inc share price target, revenues, EPS, net income and more
Lemaitre Vascular Inc quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Rev. | 70.4 | 66.6 | 64.5 | 61.1 | 64.2 | 59.9 | 55.7 | 54.8 | 55.9 | 53.5 | 48.9 | 47.4 | 50.1 | |
Cost Of Rev. | 19.6 | 18.2 | 18.3 | 15.1 | 19.3 | 18.5 | 17.1 | 17.6 | 17.4 | 16.8 | 15.6 | 16.6 | 18 | |
Gross Profit | 50.8 | 48.4 | 46.2 | 46 | 45 | 41.4 | 38.6 | 37.2 | 38.5 | 36.7 | 33.3 | 30.8 | 32.1 | |
| 30.4 | 30.6 | 27.4 | 25.6 | 28.8 | 28.8 | 25.7 | 24 | 24.1 | 24.8 | 23.1 | 21.6 | 22.5 | ||
Operating Profit | 20.4 | 17.8 | 18.8 | 20.3 | 16.1 | 12.6 | 12.9 | 13.2 | 14.4 | 11.9 | 10.2 | 9.2 | 9.6 | |
| 2.1 | -1.3 | -11 | 2.6 | 1.7 | 1.6 | 1.4 | 1.2 | 1.1 | 1 | 1 | 0.8 | 0.7 | ||
Profit Before Tax | 22.2 | 19.7 | 20.3 | 22.6 | 18.1 | 14.2 | 14 | 14.6 | 15.5 | 12.8 | 11.3 | 9.8 | 10.3 | |
Tax | 5.1 | 4 | 4.7 | 5.2 | 4.3 | 3.2 | 2.8 | 3.4 | 3.7 | 2.9 | 2.9 | 2.3 | 2.2 | |
| 17.1 | 15.7 | 15.6 | 17.4 | 13.8 | 11 | 11.2 | 11.1 | 11.8 | 9.9 | 8.5 | 7.5 | 8.1 | ||
Diluted NI Avail to Com Stockholders Ann. | 17.1 | 15.7 | 15.6 | 17.4 | 13.8 | 11 | 11.2 | 11.1 | 11.8 | 9.9 | 8.5 | 7.5 | 8.1 | |
Basic EPS | 0.8 | 0.7 | 0.7 | 0.8 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.3 | 0.4 | |
Diluted EPS After ExtraOrdinary | 0.7 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.3 | 0.4 | |
Number Of Shares End | 22.9 | 22.8 | 22.7 | 22.7 | 22.6 | 22.6 | 22.5 | 22.5 | 22.5 | 22.4 | 22.3 | 22.3 | 22.2 | |
Net Income Continuing Discontinued Operations | 17.1 | 15.7 | 15.6 | 17.4 | 13.8 | 11 | 11.2 | 11.1 | 11.8 | 9.9 | 8.5 | 7.5 | 8.1 | |
Normalized Income | 17.1 | 13 | 15.6 | 17.4 | 13.8 | 11 | 11.3 | 11 | 11.8 | 10 | 8.1 | 7.7 | 8.1 | |
Interest Income | 3.4 | - | - | 3.9 | 3 | 2.9 | 1.6 | 1.2 | 1.1 | 1 | 1 | 0.8 | 0.7 | |
Interest | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | - | - | - | - | - | - | - | |
Net Interest Income | 2.1 | -1.3 | -11 | 2.6 | 1.7 | 1.6 | 1.4 | 1.2 | 1.1 | 1 | 1 | 0.8 | 0.7 | |
EBIT | 23.5 | 21 | 21.6 | 23.9 | 19.4 | 15.5 | 17.7 | 13.2 | 14.4 | 11.9 | 12.5 | 9.2 | 9.6 | |
EBITDA | 26.2 | 23.6 | 24.2 | 26.5 | 22 | 18.1 | 20.2 | 15.6 | 16.8 | 14.3 | 14.9 | 11.6 | 12 | |
Reconciled Cost Of Rev. | 19.6 | 18.2 | 18.3 | 15.1 | 19.3 | 18.5 | 17.1 | 17.6 | 17.4 | 16.8 | 15.6 | 16.6 | 18 | |
Reconciled Depr. | 2.7 | 2.6 | 2.6 | 2.6 | 2.7 | 2.6 | 2.5 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.3 | |
Profit From Continuing Operations | 17.1 | 15.7 | 15.6 | 17.4 | 13.8 | 11 | 11.2 | 11.1 | 11.8 | 9.9 | 8.5 | 7.5 | 8.1 | |
Normalized EBITDA | 26.2 | 20.3 | 24.2 | 26.5 | 22 | 18.1 | 20.3 | 15.4 | 16.8 | 14.3 | 14.5 | 11.8 | 12 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Lemaitre Vascular Inc competitor comparison and performance snapshot within industry
Lemaitre Vascular Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Lemaitre Vascular Inc Dec-2025 Annual Revenue is $250 Million which is growth of 13.5% YoY.
- POSITIVE
Annual Net Profit Lemaitre Vascular Inc Dec-2025 Annual Net Profit is $58 Million which is growth of 31.1% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | TTM | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15.6% | 14% | 249.6 | 219.9 | 193.5 | 161.7 | 154.4 | 129.4 | 117.2 | 105.6 | 100.9 | 89.2 | 78.4 | |||
Cost Of Rev. Ann. | 7.8% | 9.7% | 71.1 | 71.1 | 69 | 66.4 | 56.8 | 53 | 44.8 | 37.4 | 31.6 | 30.2 | 26.2 | 24.2 | |
Gross Profit Ann. | 19.4% | 16.1% | 191.3 | 178.5 | 150.9 | 127.1 | 104.9 | 101.4 | 84.6 | 79.9 | 73.9 | 70.7 | 62.9 | 54.2 | |
Operating Exp. Ann. | 13.8% | 14.5% | 114 | 110.6 | 98.6 | 89.9 | 75 | 65 | 56.3 | 58.7 | 53.2 | 49.6 | 46.6 | 43 | |
Operating Profit Ann. | 31.4% | 19.1% | 77.3 | 67.9 | 52.3 | 37.2 | 29.9 | 36.4 | 28.3 | 21.2 | 20.7 | 21.1 | 16.3 | 11.2 | |
- | - | -7.7 | -5.2 | 4.7 | 3.1 | 1 | -2 | -1.1 | 0.7 | 0.6 | 0.2 | 0.1 | 0 | ||
Other Exp. Ann. | - | 162.7% | 12.5 | -0.1 | -0.8 | -3.4 | -0.1 | 0.1 | -0.2 | 7.1 | -0.2 | -0.2 | 0.3 | ||
PBT Ann. | 39.8% | 22.4% | 84.7 | 75.2 | 56.9 | 39.5 | 27.5 | 34.3 | 27.4 | 21.7 | 28.4 | 21.1 | 16.2 | 11.4 | |
Tax Ann. | 36.4% | 23.5% | 19.1 | 17.5 | 12.8 | 9.4 | 6.9 | 7.4 | 6.1 | 3.7 | 5.5 | 3.9 | 5.7 | 3.7 | |
41% | 22.2% | 65.7 | 57.7 | 44 | 30.1 | 20.6 | 26.9 | 21.2 | 17.9 | 22.9 | 17.2 | 10.6 | 7.8 | ||
Diluted NI Avail to Com Stockholders Ann. | 41% | 22.2% | 65.7 | 57.7 | 44 | 30.1 | 20.6 | 26.9 | 21.2 | 17.9 | 22.9 | 17.2 | 10.6 | 7.8 | |
EPS Ann. | 42.4% | 18.8% | 2.6 | 2 | 1.4 | 0.9 | 1.3 | 1.1 | 0.9 | 1.2 | 0.9 | 0.6 | 0.4 | ||
Diluted EPS Ann. | 40.6% | 20.1% | 2.5 | 1.9 | 1.3 | 0.9 | 1.3 | 1 | 0.9 | 1.1 | 0.9 | 0.6 | 0.4 | ||
Number Of Shares End | 1% | 2.2% | 22.7 | 22.5 | 22.3 | 22 | 21.9 | 20.4 | 20.1 | 19.6 | 19.3 | 18.7 | 18.2 | ||
Total Exp. Ann. | 11.3% | 12.4% | 181.7 | 167.6 | 156.3 | 131.7 | 118 | 101.1 | 96.1 | 84.8 | 79.8 | 72.8 | 67.2 | ||
Net Income Continuing Discontinued Operations Ann. | 41% | 22.2% | 65.7 | 57.7 | 44 | 30.1 | 20.6 | 26.9 | 21.2 | 17.9 | 22.9 | 17.2 | 10.6 | 7.8 | |
Normalized Income Ann. | 27.5% | 17.7% | 63 | 47.7 | 44 | 30.5 | 23 | 27 | 21.1 | 18.1 | 17.2 | 17.3 | 10.7 | 7.6 | |
Interest Income Ann. | - | - | - | 5 | 3.1 | 1 | 0.2 | 0.2 | 0.7 | 0.6 | 0.2 | 0.1 | 0 | ||
Interest Ann. | - | 32% | 5.2 | 5.2 | 0.2 | 2.2 | 1.3 | 0 | 0 | - | |||||
EBITDA Ann. | 35% | 19.6% | 100.4 | 90.8 | 66.8 | 49 | 36.9 | 47.6 | 37.1 | 27.1 | 32.8 | 25.2 | 19.9 | 14.6 | |
Reconciled Cost Of Rev. Ann. | 7.8% | 9.7% | 71.1 | 71.1 | 69 | 66.4 | 56.8 | 53 | 44.8 | 37.4 | 31.6 | 30.2 | 26.2 | 24.2 | |
Reconciled Depr. Ann. | 3.4% | 4.4% | 10.5 | 10.4 | 9.7 | 9.5 | 9.4 | 11.1 | 8.4 | 5.4 | 4.3 | 4.1 | 3.6 | 3.4 | |
Profit From Continuing Operations Ann. | 41% | 22.2% | 65.7 | 57.7 | 44 | 30.1 | 20.6 | 26.9 | 21.2 | 17.9 | 22.9 | 17.2 | 10.6 | 7.8 | |
Normalized EBITDA Ann. | 24.8% | 16.1% | 97.1 | 77.7 | 66.8 | 49.5 | 40 | 47.7 | 36.9 | 27.3 | 25.7 | 25.3 | 20 | 14.3 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
13.5%
2Y CAGR
13.6%
3Y CAGR
15.6%
5Y CAGR
14%
7Y CAGR
13.1%
10Y CAGR
12.3%
Total Revenue Annual growth is stable compared to historical averages.
Net Profit Ann.
1Y CHG
31.1%
2Y CAGR
38.5%
3Y CAGR
41%
5Y CAGR
22.2%
7Y CAGR
14.1%
10Y CAGR
22.2%
Net Profit Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
12.2%
2Y CAGR
10.9%
3Y CAGR
13.8%
5Y CAGR
14.5%
7Y CAGR
11%
10Y CAGR
9.9%
Operating Expenses Annual Cr growth is stable compared to historical averages.
Lemaitre Vascular Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Lemaitre Vascular Inc Dec-2025 Total Shareholders Fund is $394 Million which is growth of 16.7% YoY.
- POSITIVE
Total Assets Lemaitre Vascular Inc Dec-2025 Total Assets is $616 Million which is growth of 11.6% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
25.6% | 19.5% | 615.7 | 551.8 | 346.8 | 310.5 | 292.8 | 252.8 | 188.3 | 153.1 | 126.3 | 101.9 | 90.7 | ||
73.8% | 22.6% | 222.2 | 214.5 | 48.9 | 42.3 | 38.7 | 80.2 | 40.2 | 22.9 | 16.6 | 14.4 | 12.8 | ||
13.6% | 17.9% | 393.5 | 337.3 | 297.9 | 268.2 | 254.2 | 172.6 | 148.1 | 130.2 | 109.8 | 87.5 | 77.9 | ||
Total Capitalization Ann. | 28% | 22% | 562.2 | 505.1 | 297.9 | 268.2 | 254.2 | 208.1 | 148.1 | 130.2 | 109.8 | 87.5 | 77.9 | |
Tangible Assets Ann. | 23.7% | 43.9% | 294.5 | 235.5 | 190.2 | 155.7 | 135.5 | 47.7 | 83.3 | 86.7 | 77.7 | 54.2 | 53.8 | |
Working Capital Ann. | 46.8% | 44.3% | 431.9 | 371.6 | 164.7 | 136.4 | 118.1 | 69.1 | 71.2 | 74.3 | 67.1 | 48.5 | 47.8 | |
Invested Capital Ann. | 28% | 21.7% | 562.2 | 505.1 | 297.9 | 268.2 | 254.2 | 210.6 | 148.1 | 130.2 | 109.8 | 87.5 | 77.9 | |
Tangible Book Value Ann. | 23.7% | 43.9% | 294.5 | 235.5 | 190.2 | 155.7 | 135.5 | 47.7 | 83.3 | 86.7 | 77.7 | 54.2 | 53.8 | |
Borrowings Ann. | 123.6% | 27.6% | 185.6 | 185.7 | 19.1 | 16.6 | 15.9 | 54.8 | 15.7 | - | - | - | - | |
Net Debt Ann. | - | 65.5% | 140.4 | 142.2 | - | - | - | 11.3 | - | - | - | - | - | |
Share Issued Ann. | 1% | 2% | 24.4 | 24.2 | 23.9 | 23.7 | 23.5 | 22.1 | 21.7 | 21.1 | 20.8 | 20 | 19.8 | |
Number Of Shares End | 1% | 2.2% | 22.7 | 22.5 | 22.3 | 22 | 21.9 | 20.4 | 20.1 | 19.6 | 19.3 | 18.7 | 18.2 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
11.6%
2Y CAGR
33.2%
3Y CAGR
25.6%
5Y CAGR
19.5%
7Y CAGR
22%
10Y CAGR
21.1%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
18.6%
2Y CAGR
10.2%
3Y CAGR
12.8%
5Y CAGR
7.7%
7Y CAGR
9%
10Y CAGR
13.3%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
16.7%
2Y CAGR
14.9%
3Y CAGR
13.6%
5Y CAGR
17.9%
7Y CAGR
17.1%
10Y CAGR
17.6%
Total ShareHolders Funds Annual growth is stable compared to historical averages.
Lemaitre Vascular Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Lemaitre Vascular Inc Book Value Per Share is $18 which is growth of 14.7% YoY.
- NEUTRAL
ROE Lemaitre Vascular Inc ROE is 0% which is growth of 0% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RoA Ann. % | - | - | - | 9.80% | 9.16% | 6.84% | 9.86% | 9.62% | 10.51% | 16.42% | 15.05% | 11.00% | 9.01% | |
ROE Ann. % | - | - | - | 13.87% | 10.64% | 7.90% | 12.61% | 13.23% | 12.88% | 19.12% | 17.41% | 12.81% | 10.62% | |
ROIC % | - | - | - | 2.3 | 2.5 | 1.9 | 2.4 | 3.2 | 2.9 | 4.6 | 3.9 | 3 | 3.3 | |
OPM Ann. % | 13.7% | 4.4% | 27.21% | 23.77% | 19.22% | 18.52% | 23.59% | 21.89% | 18.07% | 19.64% | 20.92% | 18.32% | 14.23% | |
Inventory Turnover Ratio Ann. | - | - | - | 1.3 | 1.4 | 1.3 | 1.3 | 1.2 | 1.2 | 1.4 | 1.7 | 1.6 | 1.5 | |
Asset Turnover Ann. % | - | - | - | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 | |
Working Capital Turnover Ann. | -20.6% | -20.6% | 0.6 | 0.6 | 1.2 | 1.2 | 1.3 | 1.9 | 1.7 | 1.4 | 1.5 | 1.8 | 1.6 | |
Quick Ratio Ann. | - | - | - | 10.8 | 4.4 | 4.1 | 4.1 | 1.9 | 2.4 | 3.2 | 4.3 | 3.6 | 3.8 | |
Current Ratio Ann. | - | - | - | 13.1 | 6.5 | 6.4 | 6.4 | 3.8 | 4.4 | 4.8 | 6.1 | 5.6 | 5.6 | |
Interest Coverage Ratio Ann. | - | - | - | 278.4 | - | - | 16.5 | 21.9 | - | 14,223 | 1,006.1 | 1,161.1 | - | |
LT Debt To Equity Ann. | - | - | - | 0.5 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 | - | - | - | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Lemaitre Vascular Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity Lemaitre Vascular Inc Dec-2025 Cash From Operating Activity is $81 Million which is growth of 84.1% YoY.
- NEGATIVE
Net Cash Flow Lemaitre Vascular Inc Dec-2025 Net Cash Flow is $2 Million which is growth of -16.0% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
47.4% | 18.5% | 81.3 | 44.1 | 36.8 | 25.4 | 35.1 | 34.8 | 14.2 | 19.5 | 22.9 | 16.9 | 11.4 | ||
- | - | -64.9 | -200.1 | -24.7 | -10.4 | -61.1 | -52.9 | -24.1 | -7.1 | -29 | -17.2 | -3.5 | ||
- | - | -14.5 | 158.1 | -7.1 | -9.2 | 13.7 | 32.2 | -4.6 | -4.4 | 0.1 | -2.6 | 1.1 | ||
Cash Plus Cash Eqv. End Of Year Ann. | 13.9% | 1% | 28.2 | 25.6 | 24.3 | 19.1 | 13.9 | 26.8 | 11.8 | 26.3 | 19.1 | 24.3 | 27.5 | |
Net Increase In Cash Plus Cash Eqv.s Ann. | -32.3% | -33.7% | 1.8 | 2.1 | 4.9 | 5.8 | -12.3 | 14.1 | -14.5 | 8 | -6 | -2.9 | 9 | |
Cash Plus Cash Eqv. Begin Of Year Ann. | 22.6% | 16.8% | 25.6 | 24.3 | 19.1 | 13.9 | 26.8 | 11.8 | 26.3 | 19.1 | 24.3 | 27.5 | 18.7 | |
Income Tax Paid Supplemental Data Ann. | 17.3% | - | 13.4 | - | 7.6 | 8.3 | - | - | - | 5.5 | 3.2 | 4.2 | 4.8 | |
Interest Paid Supplemental Data Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Capex Ann. | - | - | -6.8 | -7 | -7.3 | -3.2 | -4.9 | -3 | -3.8 | -3.1 | -6.4 | -2.8 | -2.3 | |
Issuance Of Capital Stock Ann. | - | - | - | 6.4 | 6.2 | 3.5 | 63.2 | 6 | 4.9 | 3 | 5.5 | 1.4 | 4.8 | |
Issuance Of Debt Ann. | - | - | 169.3 | - | 65 | - | - | - | - | - | ||||
Repayment Of Debt Ann. | - | - | - | - | -39 | -26 | - | - | - | - | ||||
Repurchase Of Capital Stock Ann. | - | - | - | - | - | -0.6 | -0.8 | -0.6 | -0.7 | -0.7 | -0.8 | -0.3 | -0.3 | |
Free Cash Flow Ann. | 49.7% | 18.6% | 74.5 | 37.2 | 29.5 | 22.2 | 30.2 | 31.8 | 10.4 | 16.5 | 16.5 | 14.1 | 9.2 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
84.4%
2Y CAGR
48.6%
3Y CAGR
47.4%
5Y CAGR
18.5%
7Y CAGR
22.6%
10Y CAGR
21.7%
Cash from Operating Activity Annual growth is higher than historical averages.